Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial Press Trust of India Jul 14, 2020 Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe…
Hydroxychloroquine for coronavirus shows no benefit, possible harm in study awaiting validation Reuters Apr 23, 2020 An analysis of Veterans Health Administration (VA) data found that 28 per cent of 97 patients given hydroxychloroquine along with…
Using body clock improves patient outcomes for rheumatoid arthritis Usha Sharma May 5, 2015 A team of scientists have found evidence that co-ordinating the time of treatment with the timing of disease symptoms can increase…
